Clinical Trial Update: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial assessing continuous hyperthermic peritoneal perfusion with cisplatin in children with peritoneal cancers. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma
• Desmoplastic Small Round Cell Tumor
• Gastrointestinal Neoplasms
• Neuroblastoma
• Peritoneal Neoplasms
• Retroperitoneal Neoplasms
• Rhabdomyosarcoma
• Wilms Tumor

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Peritoneal Neoplasms, Retroperitoneal Neoplasms | Phase 1 | Status: COMPLETED